Related Experiment Video
Updated: Sep 15, 2025

08:37
A Rapid and Facile Pipeline for Generating Genomic Point Mutants in C. elegans Using CRISPR/Cas9 Ribonucleoproteins
Published on: April 30, 2018
7.7K
Synthetic guide sequence to generate CRISPR-Cas9 entry strains in C. elegans
1School of Biomolecular and Biomedical Science, University College Dublin, Dublin, Ireland.
Biorxiv : the Preprint Server for Biology
|July 16, 2025
Summary
Researchers developed a new synthetic guide RNA sequence for CRISPR/Cas9 genome editing in *C. elegans*. This sequence provides an alternative to the standard dpy-10 guide RNA for creating entry strains when dpy-10 is unsuitable.
Area of Science:
- Molecular Biology
- Genetics
- Developmental Biology
Background:
- CRISPR/Cas9 genome editing is a routine technique in *C. elegans* research for generating mutants and tagging genes.
- The efficiency of single-guide RNA (sgRNA) sequences in CRISPR experiments can be highly variable.
- Using an intermediate entry strain with an efficient sgRNA, like the *dpy-10* guide RNA, is a common strategy to improve knock-in efficiency.
Purpose of the Study:
- To address the limitations of the *dpy-10* guide RNA for creating CRISPR entry strains in *C. elegans*.
- To introduce a novel, synthetic sgRNA sequence as a viable alternative for generating entry strains.
- To provide a robust tool for *C. elegans* genome editing, especially in cases where the *dpy-10* sequence is not applicable.
Main Methods:
- Design and synthesis of a novel sgRNA sequence (GCTATCAACTATCCATATCG) not present in the *C. elegans* genome.
- Utilizing the synthetic sgRNA to create intermediate entry strains in *C. elegans* via CRISPR/Cas9.
- Evaluating the knock-in efficiency of the synthetic sgRNA for entry strain generation.
Main Results:
- The synthetic guide sequence, GCTATCAACTATCCATATCG, demonstrated successful generation of entry strains in *C. elegans*.
- Knock-in efficiency for the synthetic sgRNA ranged from 1-11%, which is lower than the *dpy-10* method but sufficient for many applications.
- The synthetic sgRNA is effective even when the *dpy-10* sequence is unsuitable due to genetic linkage or co-CRISPR marker requirements.
Conclusions:
- A novel synthetic sgRNA sequence offers a valuable alternative for creating *C. elegans* entry strains.
- This new tool expands the utility of CRISPR/Cas9 genome editing in *C. elegans*, particularly in challenging genetic contexts.
- The synthetic sgRNA enhances the CRISPR toolkit for researchers needing flexible and robust genome engineering strategies.
More Related Videos
Related Concept Videos
CRISPR/Cas9 Genome Editing
272
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
272
CRISPR
53.0K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
53.0K

